• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毛细胞白血病亚群的鉴定将p35定义为Ii的人类同源物。

Identification of hairy cell leukemia subset defining p35 as the human homologue of Ii.

作者信息

Spiro R C, Sairenji T, Humphreys R E

出版信息

Leuk Res. 1984;8(1):55-62. doi: 10.1016/0145-2126(84)90031-6.

DOI:10.1016/0145-2126(84)90031-6
PMID:6583461
Abstract

A molecule defining a subset of patients with hairy cell leukemia (HCL) on the basis of being abundantly labeled with [35S]methionine, was demonstrated to be the human homologue of murine Ii, a glycoprotein which lacks alloantigenic variation and is associated non-covalently with Ia antigens. In one-dimensional SDS-polyacrylamide gradient gel electrophoresis, the HCL-subset-defining molecule migrated with HLA-DR molecules which were immunoprecipitated with a specific heteroantiserum. These molecules were further defined in two-dimensional, SDS and non-equilibrium pH gradient electrophoresis of either membrane preparations or immunoprecipitates formed with various antibodies. [35S]methionine-labeling of the HCL-subset-defining molecule was greater in hairy leukemic cells than in lymphoblastoid cell lines. The subset-defining species was associated non-covalently with HLA-DR alpha and beta chains and ran electrophoretically at a position described for murine and human Ii molecules (in terms of pI and weight). Metabolic labeling of HLA-A,-B and -DR was also increased in HCL cells relative to lymphoblastoid cell lines. A separate protein, of 41,000 mol. wt and pI of 7-8, resembled another Ii-associated molecule which has been described in murine and human studies.

摘要

一种基于被[35S]甲硫氨酸大量标记来定义毛细胞白血病(HCL)患者亚群的分子,被证明是小鼠Ii的人类同源物,Ii是一种缺乏同种异型抗原变异且与Ia抗原非共价结合的糖蛋白。在一维SDS-聚丙烯酰胺梯度凝胶电泳中,定义HCL亚群的分子与用特异性异种抗血清免疫沉淀的HLA-DR分子一起迁移。这些分子在二维SDS和非平衡pH梯度电泳中进一步得到定义,电泳对象是膜制剂或用各种抗体形成的免疫沉淀物。毛细胞白血病细胞中定义HCL亚群的分子的[35S]甲硫氨酸标记比淋巴母细胞系中的更强。定义亚群的物种与HLA-DRα链和β链非共价结合,并在电泳时位于描述的小鼠和人类Ii分子的位置(就pI和分子量而言)。相对于淋巴母细胞系,HCL细胞中HLA-A、-B和-DR的代谢标记也增加。一种分子量为41,000且pI为7 - 8的单独蛋白质,类似于在小鼠和人类研究中描述的另一种与Ii相关的分子。

相似文献

1
Identification of hairy cell leukemia subset defining p35 as the human homologue of Ii.毛细胞白血病亚群的鉴定将p35定义为Ii的人类同源物。
Leuk Res. 1984;8(1):55-62. doi: 10.1016/0145-2126(84)90031-6.
2
Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.在表达或不表达II类抗原的丁酸盐处理的伯基特淋巴瘤细胞系以及毛细胞白血病细胞中Ii合成、加工和周转的动力学。
J Immunol. 1985 May;134(5):3539-49.
3
Demonstration of p35 in hairy cell leukemia of Japanese patients.
Cancer. 1984 May 15;53(10):2111-4. doi: 10.1002/1097-0142(19840515)53:10<2111::aid-cncr2820531020>3.0.co;2-c.
4
Expression of p35 in hairy leukemic cells from Japanese patients.p35在日本患者毛细胞白血病细胞中的表达。
Hematol Oncol. 1984 Oct-Dec;2(4):359-64. doi: 10.1002/hon.2900020405.
5
Enhanced Ii expression after n-butyrate treatment of a P3HR-1 Burkitt's lymphoma subline which does not express HLA-D.
Hematol Oncol. 1984 Jul-Sep;2(3):239-47. doi: 10.1002/hon.2900020303.
6
Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia.毛细胞白血病患者来源的淋巴母细胞系的爱泼斯坦-巴尔病毒转化分析及表型特征
Am J Hematol. 1983 Dec;15(4):361-74. doi: 10.1002/ajh.2830150407.
7
Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrate.
Blood. 1984 Jul;64(1):33-7.
8
Decreased expression of Ii-derived p25 and of P67/69 in hairy leukemic cells.
Leuk Res. 1988;12(10):787-94. doi: 10.1016/0145-2126(88)90030-6.
9
Simplification of two-dimensional gel patterns of HLA class II antigens.
Tissue Antigens. 1986 Aug;28(2):72-83. doi: 10.1111/j.1399-0039.1986.tb00464.x.
10
Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.从HLA-DR4、7和w9纯合细胞系中鉴定MT3分子。
J Immunol. 1984 Dec;133(6):3211-9.

引用本文的文献

1
Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy.在癌症免疫治疗中靶向 MHC Ⅱ类抗原呈递途径。
Oncoimmunology. 2012 Sep 1;1(6):908-916. doi: 10.4161/onci.21205.